Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

Medicare Monday: Billing code basics for biologics in Part B

March 20, 2017

MedPAC's consolidated billing proposal would put access to important Part B medicines at risk.

Read More

How drug importation schemes could increase U.S. law enforcement burdens

March 16, 2017

A few examples of how drug trafficking and importation proposals can impact law enforcement.

Read More

Medicare Monday: A closer look at Part B spending

March 13, 2017

Putting Part B drug spending growth in the context of overall program spending.

Read More

PhRMA Statement on Dr. Scott Gottlieb’s Nomination to Lead the U.S. Food and Drug Administration

March 10, 2017

Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl issued the following statement on President Trump’s nomination of Dr. Scott Gottlieb to lead the U.S. Food and Drug Administration (FDA).

Read More

Stakeholders Agree: Modernize the legal framework to support move to value-driven health care

March 6, 2017

A recent white paper takes a deeper look at how reforms focused on Stark and Anti-Kickback could help the move toward value-driven health care.

Read More

Medicare Monday: New study further confirms increased use of generics after Part D

March 6, 2017

There has been a steady increase year after year in the generic utilization rate for Part D beneficiaries.

Read More

Guest Post: Room for optimism in ALS research

March 3, 2017

We are pleased to host a Q&A with Rob Goldstein from the ALS Therapy Development Institute to discuss treating rare diseases such as ALS.

Read More

Guest Contributor: Debra of America on Epidermolysis Bullosa

March 3, 2017

Read about how Debra of America is promoting gene therapy to drive innovative treatments for rare diseases like Epidermolysis Bullosa.

Read More

Guest Post: A Cure for Ellie on Leukodystrophy-LBSL

March 2, 2017

We’re excited to share a new blog post from Beth McGinn at A Cure for Ellie, an organization founded following her daughter’s diagnosis of Leukodystrophy-LBSL

Read More

Case Study: How one online pharmacy knowingly endangered U.S. consumers

March 2, 2017

A real example of one online pharmacy that was caught selling counterfeit medicines to U.S. consumers.

Read More